SK bioscience

About SK bioscience

SK Bioscience is dedicated to promoting human health from prevention to cure, focusing on the development and production of vaccines and biopharmaceuticals to address global health challenges.

Products & Services

Self-Developed Products:Vaccines and biopharmaceuticals developed in-house by SK Bioscience.

Introduced/Distributed Products:Products introduced or distributed by SK Bioscience for domestic and international markets.

MenQuadfi (Meningococcal Vaccine):A meningococcal vaccine launched in collaboration with Sanofi, targeting infants and expanding vaccination coverage.

Specialties

Vaccine Development Biopharmaceuticals R&D in Bioscience CDMO/CMO Services Global Health Solutions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 30000000 MR: - FA: up to USD 30 million FAN: 30000000	D: 2026-01-22 FD: 2026-01-22	1 investors

Grant Latest

2026-01-22

$30.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

SK bioscience Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised